» Authors » Daiva Urboniene

Daiva Urboniene

Explore the profile of Daiva Urboniene including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 20
Citations 68
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Pereckaite L, Vaguliene N, Vitkauskaite A, Vitkauskiene A, Urboniene D
J Clin Med . 2024 Nov; 13(21). PMID: 39518552
Severe clinical course and mortality from COVID-19 are mostly associated with increased concentrations of IL-6 and IL-10. Findings from clinical trials suggest that both statins and renin-angiotensin-aldosterone system inhibitors (RAASI)...
2.
Ulevicius J, Jasukaitiene A, Bartkeviciene A, Dambrauskas Z, Gulbinas A, Urboniene D, et al.
Int J Mol Sci . 2024 Jul; 25(13). PMID: 39000195
Ovarian cancer (OC) poses a significant global health challenge with high mortality rates, emphasizing the need for improved treatment strategies. The immune system's role in OC progression and treatment response...
3.
Vitkauskaite A, Urboniene D, Celiesiute J, Jariene K, Paskauskas S, Vaitkiene D, et al.
Medicina (Kaunas) . 2024 Mar; 60(3). PMID: 38541074
Cervical cancer (CC) remains a major public health problem, ranking as the fourth most common cause of cancer incidence and mortality in women globally. The development of CC is believed...
4.
Ulevicius J, Jasukaitiene A, Bartkeviciene A, Dambrauskas Z, Gulbinas A, Urboniene D, et al.
Cancers (Basel) . 2024 Jan; 16(1). PMID: 38201617
Surgical treatment is a cornerstone of ovarian cancer (OC) therapy and exerts a substantial influence on the immune system. Immune responses also play a pivotal and intricate role in OC...
5.
Bartkeviciene A, Jasukaitiene A, Zievyte I, Stukas D, Ivanauskiene S, Urboniene D, et al.
Cancers (Basel) . 2023 Sep; 15(18). PMID: 37760608
Pancreatic cancer, particularly pancreatic ductal adenocarcinoma (PDAC), has an immune suppressive environment that allows tumour cells to evade the immune system. The aryl-hydrocarbon receptor (AHR) is a transcription factor that...
6.
Karaliute R, Leleika A, Apanaviciute I, Kazakevicius T, Mizariene V, Zabiela V, et al.
Medicina (Kaunas) . 2022 Aug; 58(8). PMID: 36013520
Background and objectives: To identify clinical, echocardiographic, and laboratory parameters that affect the early recurrence of atrial fibrillation (AF) after restoring sinus rhythm (SR) by electrical cardioversion (ECV), and to...
7.
Stakisaitis D, Kapocius L, Valanciute A, Balnyte I, Tamosuitis T, Vaitkevicius A, et al.
Biomedicines . 2022 May; 10(5). PMID: 35625699
Sex differences identified in the COVID-19 pandemic are necessary to study. It is essential to investigate the efficacy of the drugs in clinical trials for the treatment of COVID-19, and...
8.
Musteikiene G, Miliauskas S, Zaveckiene J, Urboniene D, Vitkauskiene A, Zemaitis M, et al.
J Clin Tuberc Other Mycobact Dis . 2021 Sep; 25:100275. PMID: 34541339
Analysis of inflammatory biomarkers and lymphocytes during the treatment of tuberculosis (TB) could yield findings that influence the routine clinical practice and use of new anti-TB drugs. This study aimed...
9.
Pereckaite L, Dambrauskiene A, Urboniene D, Sadauskas S, Petrikonis K, Naudziunas A, et al.
Medicina (Kaunas) . 2021 Feb; 57(2). PMID: 33562085
: Serologic testing is a useful additional method for the diagnosis of COVID-19. It is also used for population-based seroepidemiological studies. The objective of the study was to determine SARS-CoV-2...
10.
Karaliute R, Jureviciute J, Jurgaityte J, Rimkute A, Mizariene V, Baksyte G, et al.
Clin Interv Aging . 2020 Oct; 15:1917-1925. PMID: 33116446
Purpose: Spectral tissue Doppler-derived E/e' ratio has been proposed as the best parameter for prediction of atrial fibrillation (AF). Relaxation and contraction are equivalent parts of a continuous cardiac cycle,...